CD274 and small cell lung carcinoma: The aim of this retrospective, multicenter, observational study was to determine whether total BTS is associated with prognosis, particularly OS, the most critical endpoint in cancer treatment, in patients with SCLC who receive chemotherapy plus PD-L1 inhibitor as first-line therapy.